Status: Recruiting
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
The objective of this study is to evaluate the safety and effectiveness of LDGraft (investigational device) compared to 100% human tissue product allograft bone (control) when applied in an ALIF procedure in the treatment of patients with lumbar degenerative disc disease (DDD).
Participants needed: 40
Trial details
Phase: Phase 1, Phase 2Age: 22-80Biological sex: AllType: InterventionalSponsor: Locate Bio Pty LtdUpdated: May 27, 2026Locations: 3
Eligibility criteria
Skeletally mature adults ≥22 and ≤80 years at the time of surgery [+11]
Previous lumbar spine instrumentation (i.e., anterior disc replacement, interspi... [+21]